Long-term infliximab treatment for Behçet's disease.

Suppr

超能文献

作者信息

Takamoto Mitsuko, Kaburaki Toshikatsu, Numaga Jiro, Fujino Yujiro, Kawashima Hidetoshi

出版信息

Jpn J Ophthalmol. 2007 May-Jun;51(3):239-40. doi: 10.1007/s10384-006-0424-z. Epub 2007 Jun 7.

DOI:10.1007/s10384-006-0424-z

PMID:17554493

Abstract

摘要

相似文献

Long-term infliximab treatment for Behçet's disease.

Jpn J Ophthalmol. 2007 May-Jun;51(3):239-40. doi: 10.1007/s10384-006-0424-z. Epub 2007 Jun 7.

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.

Jpn J Ophthalmol. 2007 May-Jun;51(3):191-6. doi: 10.1007/s10384-006-0425-y. Epub 2007 Jun 7.

Cataract surgery under infliximab therapy in a patient with Behçet's disease.

J Ocul Pharmacol Ther. 2009 Oct;25(5):467-70. doi: 10.1089/jop.2009.0054.

Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.

Br J Ophthalmol. 2011 Sep;95(9):1245-50. doi: 10.1136/bjo.2010.194464. Epub 2010 Dec 22.

Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S58-63. Epub 2011 Sep 27.

Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease.

Int Ophthalmol. 2005 Jun;26(3):83-92. doi: 10.1007/s10792-006-9006-9. Epub 2006 Sep 23.

Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.

Inflamm Bowel Dis. 2009 Dec;15(12):1769-71. doi: 10.1002/ibd.20869. Epub 2009 Jan 28.

Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.

J Rheumatol. 2009 Apr;36(4):855. doi: 10.3899/jrheum.081063.

Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.

Int J Infect Dis. 2009 Sep;13(5):e325. doi: 10.1016/j.ijid.2008.11.007. Epub 2009 Jan 20.

Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.

J Ocul Pharmacol Ther. 2010 Dec;26(6):627-30. doi: 10.1089/jop.2010.0031. Epub 2010 Nov 2.

引用本文的文献

Behçet's disease physiopathology: a contemporary review.

Auto Immun Highlights. 2016 Dec;7(1):4. doi: 10.1007/s13317-016-0074-1. Epub 2016 Feb 12.

Update on the therapy of Behçet disease.

Ther Adv Chronic Dis. 2014 May;5(3):112-34. doi: 10.1177/2040622314523062.

Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.

Jpn J Ophthalmol. 2012 Nov;56(6):536-43. doi: 10.1007/s10384-012-0182-z. Epub 2012 Oct 2.

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.

Biologics. 2012;6:5-12. doi: 10.2147/BTT.S27343. Epub 2011 Dec 29.

Use of biologic agents in ocular manifestations of rheumatic disease.

Int J Rheumatol. 2012;2012:203819. doi: 10.1155/2012/203819. Epub 2011 Dec 15.

Cutting-edge issues in autoimmune uveitis.

Clin Rev Allergy Immunol. 2011 Oct;41(2):214-23. doi: 10.1007/s12016-011-8267-x.

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Am J Ophthalmol. 2008 Dec;146(6):828-36. doi: 10.1016/j.ajo.2008.06.019. Epub 2008 Aug 16.

本文引用的文献

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.

Arthritis Rheum. 2005 Aug;52(8):2478-84. doi: 10.1002/art.21231.

Anti-TNF-alpha therapy for sight threatening uveitis.

Br J Ophthalmol. 2005 May;89(5):533-6. doi: 10.1136/bjo.2003.037192.

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.

J Rheumatol. 2004 Jul;31(7):1362-8.

Infliximab in the treatment of refractory posterior uveitis.

Ophthalmology. 2003 Jul;110(7):1449-53. doi: 10.1016/S0161-6420(03)00406-8.

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

Lancet. 2001 Jul 28;358(9278):295-6. doi: 10.1016/s0140-6736(01)05497-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验